Author: [AUTHOR] Published on 10/23/2020 1:28:00 PMASCPT Early Career (EC) Community and Oncology (ONC) Community Members-Only Webinar
Title: Translational and Clinical Pharmacology Considerations in the Development of Immune-Oncology Drugs (Encore Presentation)
Date and Time: Monday, December 7, 2020, 8:00 pm ET
Speaker: Maulik Patel, PharmD, PhD
Moderators: Pooja Manchandani, PhD, and Malek Okour, PhD
Description: This will be a special encore presentation to ensure our members in Asia Pacific locations are able to participate in the ASCPT Webinar Program and have an opportunity for live Q&A with the presenter!
This session will highlight the hallmarks of immuno-oncology drug development and expand on pharmacometrics, clinical pharmacology and statistical strategies to optimize clinical trial design and development of immune-oncology drugs. Highlights of this session will include:
- Fundamental biology underpinnings and trajectory of immune-oncology drug development and how this differs from the standard clinical development paradigm in oncology.
- Role and impact of clinical pharmacology aspects to support immune-oncology drug development for monotherapy and combination.
- Modeling and simulation strategies and clinical trial designs for early development and pivotal trials.
Registration Link: https://us02web.zoom.us/webinar/register/3016033941627/WN_L93iQxWKTeuPsp0NOFxUaw
